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I. INTRODUCTION 
At least 30 species of nonfermentative Gram-negative 
bacilli have been reported from clinical material. Most of 
these belong to the genera Achromobacter, Acinetobacter, 
Alcaligenes, Chromobacterium, Flavobacterium and Pseudomonas. 
Many of these genera are inadequately characterized, and 
their affiliation with other bacterial groups is uncertain. 
The most common and most important clinically is Pseudomonas, 
a member of the family Pseudomonodaceae and order Pseudo-
monadales. According to Bergey's Manual of Determinative 
Bacteriology (1974), there are 235 species in the genus, 
29 of which are well characterized, 74 more or less ade-
quately described, and 132 considered "species incertae 
sedis." The 29 well-characterized species have long been 
recognized as pathogens for plants, animals and man. Serious 
attempts to better characterize the pseudomonads, as they 
are collectively termed, are still being undertaken in a 
number of laboratories across the country. 
The pseudomonads are Gram-negative, straight or slightly 
curved rods, that occur singly, in small bundles, or short 
chains. All but one species are motile, possessing one or 
more polar flagella, at one or both ends. No sporeformers 
exist and all are catalase positive. They are strict 
l 
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aerobes with oxidative metabolism, never fermentative. In 
the presence of nitrate some organisms are able to grow 
anaerobically. A few species give weak or negative oxidase 
tests but the majority are strongly oxidase positive. The 
temperature range depends on the species; for the group, 
growth occurs over the wide range of 4-42C. Some members of 
the genus accumulate poly-B-hyroxybutyrate as an intracellu-
lar storage form of carbon. A noteworthy characteristic of 
the pseudomonads is their simple nutritional requirements. 
All species with the exception of Ps. maltophilia are able 
to grow in a solution composed of mineral salts, ammonia and 
a carbon-containing compound. Due to their simple nutri-
tional requirements and their ability to utilize any of a 
wide variety of organic compounds, many pseudomonads are able 
to survive and grow in weak, old, or improperly prepared 
disinfectant solutions. 
A trait used as an aid in identification is the pro-
duction of various pigments, one of which is pyocyanin, a 
fluorescent pigment produced only by Ps. aeruginos~. It is 
a deep blue phenazine dye which is chloroform soluble. 
Another pigment produced by Ps. aeruginosa and a few other 
pseudomonads is fluorescein, a water but not chloroform-
soluble pigment. Fluorescence is seen under an ultraviolet 
light (wave-length below 260 nm). Fluorescein, also known 
as pyoverdin, resorcinolphthalein and dihydroxyfluorane, 
exhibits a yellow-green hue. Other pigments liberated by 
Ps. _aeruginosa and other species include the water-soluble 
pyorubin, (bright red) and pyomelanin (brown to black). The 
production of these pigments is enhanced during propaga-
tion in iron-deficient or special media, such as media A and 
B of King, et al. (1954) or that of Wahba and Darrell (1965). 
All these pigments may occur individually or in combination 
in any pigment-producing strain. 
Pseudomonas species are widely distributed in nature 
especially in soil, fresh water and marine environments. 
However, doubt exists as to whether all members are truly 
free living organisms. This is due to the fact that water 
environments not subject to fecal pollution do not harbor 
Ps. aeruginosa (Reitler and Seligmann, 1957). Moreover, the 
isolation of Ps. aeruginosa in wild animals and birds is a 
rare event (Hoadley and McCoy, 1968). Values of fecal car-
riage in man of this organism vary considerably. In adults, 
not associated with hospital environments, carriage is re-
ported to be between six and 12 percent (Stoodley and Thorn, 
1970). Ps. aeruginosa may be cultured from the skin or the 
upper respiratory tract of 20 percent of hospital in-patients 
(Grogan, 1966). Yet colonization by the organism of the gut 
of healthy persons is rare, even with oral ingestion of as 
many as 106 organisms (Buck and Cook, 1969). Ps. aeruginosa 
thrives best in a moist environment but can tolerate dry 
conditions. Darrel and Wahba (1964) isolated the organism 
from 5 percent of samples taken from hospital dust. 
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Other pseudomonads isolated from clinical material 
include Ps. put ida, Ps . fl uorescens, Ps . stutzer i ., Ps. 
cepacia, Ps. maltophilia, Ps. diminuta, Ps. alcaligenes , Ps . 
Eseudoalcaligenes, and Ps . putrefaciens. The habitats of 
some of these are not known but probably, like most pseudo-
monads, they are saprophytes in the terrestrial and aquatic 
e nvironme nts. Possible exceptions are Ps . pseudomallei, 
the cause of meliodosis, a glanders-like disease, of humans 
and animals in S.E. Asia, and Ps. mallei, t h e cause of 
glanders (farcy), a natural disease of equines, and occasion-
ally of humans. 
Since 1950, interest in the pseudomonads, especially 
Ps. ~eruginosa, has increased . This organism has become on~ 
of the most common causes of nosocomial infections. Serious 
and sometimes fatal infections occur in newborn infants. 
S~rious infections in adults occur when the patient has a 
lowered resistance which allows Ps . aeruginosa to assume the 
role of an opportunistic pathogen (Myrvik, et al., 1974) . 
Such infect ions h ave increased in incidence because the 
number of susceptible pati e nts has grown . Suscepti~le 
individuals include the elderly , those who are afflicted 
with chronic and degenerative diseases , persons on prolonged 
antibiotic treatment, immunos uppressive and anticancer drugs, 
and victims of se rious burns. With an increasing number of 
infections being attributed to nonfermentors, accurate 
identification requiring rapid and r e liabl e tests become 
essenti a l. 
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The majority of biochemical tests used in the diagnostic 
laboratory are geared to the identification of the fermenta-
tive Enterobacteriaceae. Many of these tests are inappropri-
ate for characterization of Gram-negative nonfermentative 
bacilli (NFB). Until recently these facts dictated that a 
nonfermentative bacterial isolate be identified no further 
than the generic level, often reported as "Pseudomonas sp." 
'l'he taxonmic identity of Gram-negative nonfermentative 
bacilli is still far from being well defined. Significant 
progress in the identification and classification of these 
bacteria has been made in recent years (King, 1964; Stanier 
et al., 1966; Ballard et al., 1968; Gilardi, l968a, l968b, 
1973; Gilardi et al., 1975; Bauman et al., l968a, l968b; 
Pinter and Bende, 1968; Pickett and Manclark, 1970; Pickett 
and Pedersen, 1970; Pedersen et al., 1970; Hugh and Gilardi, 
1974; Otto and Pickett, 1976; and Oberhofer et al., 1977). 
Furthermore, identification has been facilitated through 
the introduction of various commercial kits including the 
Oxidative Screening Kit and Oxidative Confirmatory Kit (Key 
Scientific Products Company), API 20E (Analytab Products), 
and most recently the Oxi/Ferm Tube (Hoffman-LaRoche). 
A number of researchers have pointed out that anti-
microbial susceptibility patterns may be useful as an aid 
in the identification and differentiation of bacterial 
species. As with biochemical characterization, the majority 
of research involving antimicrobial susceptibility testing 
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has been done with bacteria possessing fermentative metabolism 
(Eickhoff et al., 1966; Kock and Rose, 1966; Lerner and Wein-
stein, 1967; Ramirez, 1968; Zabransky et al., 1969; Washing-
ton and Bourgeois, 1969; Washington, 1969; Russell, 1969; 
Wilfert et al., 1970; Greenup and Blazevic, 1971; Friedman and 
MacLowry, 1973; Darland, 1975; Klein et al., 1975; Sielaff 
et al., 1976; Hall, 1976; and more recently Storey, 1977). 
Efforts to use the antimicrobial susceptibility patterns of 
Gram-negative, nonfermentative bacilli as an aid in char-
acterization have intensified. Von Graevenitz and Redys 
(1968) were the first researchers to suggest that antibiotic 
disk sensitivities be used as an aid in the identification of 
this group. The susceptibility of Bacterium anitratum 
(~cinetobacter anitratus) to 16 antimicrobial agents was 
investigated by Hugh and Reese (1969). Washington (1969) 
used nine antibiotics to study the susceptibilities of sev-
eral genera and groups of Gram-negative nonfermentative 
bacilli. Lowbury et al. (1969) tested the susceptibility 
of 1452 strains of Pseudomonas aeruginosa isolated from burn 
patients over a four year period to three antibiotics and 
observed the emergence of strains highly resistant to car-
benicillin. Klastersky (1971) isolated fermentative and 
nonfermentative bacteria from patients with disseminated 
malignant disease and studied the relationship between site 
of isolation and their sensitivity to eight antibiotics. 
Gilardi (197lc) published the first major study which utilized 
7 
antimicrobial susceptibility patterns as a diagnostic aid 
in the identification of Gram-negative nonfermentative 
bacteria. Moody et al. (1972) studied the susceptibility 
patterns of 100 "pseudomonads" other than Pseudomonas aerugi-
nosa which were recovered from cancer patients, and sug-
gested these patterns be used as an aid in preliminary 
identification of these organisms. Martin et al. (1973) 
examined the biochemical characteristics and the antimi-
crobial susceptibilities of 183 strains of Pseudomonas 
fluorescens and Pseudomonas ££!ida isolated from clinical 
specimens. Friedman and MacLowry (1973) described a computer 
program utilizing a Baysean mathematical model to identify 
bacteria, fermenters and nonfermenters, solely on the basis 
of their susceptibility patterns to ll antibiotics. Sielaff 
et al. (1976) and Bucket al. (1977) employed computers 
and a semi-automated device for susceptibility testing 
(autobac I, Pfizer, Inc.) to devise a scheme for the iden-
tification of bacterial isolates that are based strictly on 
susceptibility patterns to various antimicrobial agents. 
Most recently Oberhofer et al. (1977) reported on the bio-
chemical and antibiotic susceptibility testing of 593 strains 
of nonfermentative Gram-negative bacteria isolated from 
clinical specimens. 
Of all the Gram-negative nonfermentative bacteria, 
Pseudomonas aeruginosa is one of the most resistant to chemo-
therapeutic agents. The polymyxins and colistin, antibiotics 
produced by species of the genus Bacillus were for many 
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years the only antimicrobials effective against Ps. aerug:i,_-
nosa (Ayliffe et al., 1969). Subsequently, gentamicin pro-
duced from Micromonospora and carbenicillin, a semi-synthetic 
penicillin, became availa.ble to the physician. In the last 
two to four years two other aminoglycosides were introduced; 
tobramycin, formerly designated nebramycin factor 6, and 
amikacin both of which have a high degree of activity against 
Ps. aeruginosa and especially to those strains that have 
developed resistance to gentamicin. 
The innate ability of bacteria to adapt to new environ-
ments creates an ongoing problem for the physician with 
regard to his selection of effective chemotherapeutic agents 
and for the medical microbiologist in his attempt to fully 
identify microorganisms. The antibiotic susceptibility 
pattern of any species of bacteria is dynamic and is af-
fected by various factors including mutation, excessive use 
of antibiotics, and the introduction of new antimicrobial 
agents (Gilardi, 197lc). Thus the reaffirmation of anti-
biotic susceptibility studies is mandatory. 
This study was undertaken, chiefly, for the purpose of 
characterizing biochemically a random sample of nonfermenta-
tive bacilli obtained from local hospitals and determine the 
prevalence of Ps. aeruginosa among them. A second objective 
was to compare the antiobiogram patterns obtained in this 
study with those reported by other investigators, and thirdly 
to establish a baseline for future comparative studies. 
II. MATERIALS AND METHODS 
One hundred and thirty-seven isolates of Gram-negative, 
nonfermentative bacilli were obtained from various clinical 
materials (Table 1) from in-and-out patients at the labora-
tories of Dameron and St. Joseph's Hospitals in Stockton, 
California, between January 1976 and February 1977. The 
Oxi/Ferm Tube (Roche Diagnostics, Nutley, N.J.) system of 
identification was used in the initial and presumptive iden-
tification of all the isolates. In addition, 14 selected 
enzymatic and oxidative tests, and growth characteristic 
studies were performed on each. All clinical isolates were 
subcultured on Hektoen Enteric Agar (Difco Products, Detroit, 
Mich.) to obtain well-isolated colonies and ascertain their 
purity. Individual colonies were then transferred to Tryp-
tic Soy Agar (TSA) slants, incubated for 18-24 hours, then 
stored at two to eight degrees C. These stock cultures 
were maintained by repeated subculture every two weeks. Cul-
tures were incubated at 36 ~ lC (except for one test to 
determine ability of the organism to grow at 42C) for six 
hours to six days depending on the test. 
The tests listed below were used to investigate the 
biochemical activities of the organisms in this study: 
1. OxifFerm Tube (anaerobic-dextrose fermentation, arginine 
dihydrolase, nitrogen gas production, hydrogen sulfide gas 
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production, indole production, xylose oxidation, aerobic-
dextrose oxidation, urease activity, and citrate utiliza-
tion); 2. Confirmatory Tests (oxidase activity, pigment 
production, growth on SS agar, ONPG, gelatin hydrolysis, 
gluconate, acetamide, carbohydrate oxidation test (C.O.T.) 
tablets for fructose, maltose, mannitol, arabinose, lactose, 
and rhamnose, and finally growth at 42C). In addition to 
biochemical activities, antimicrobial susceptibility testing 
was conducted. The reaction of each isolate to 17 anti-
microbial agents (polymyxin B 300U; gentamicin lOug; tobra-
mycin lOug; neomycin 30ug; carbenicillin lOOug; gantrisin 
300ug; penicillin lOU; tetracycline 30ug; kanamycin 30ug; 
ampicillin lOug; nalidixic acid 30ug; nitrofurantoin 300ug; 
streptomycin lOug; chloramphenicol 30ug; lincomycin 2ug; 
erythromycin 15ug; and cephalothin 30ug) was studied uti-
lizing the Bauer-Kirby agar disk diffusion technique 
(Table 2). 
To test for oxidase activity Patho Tee test strips 
(General Diagnostics, Morris Plains, N.J.) were used. ONPG 
tablets, gelatin hydrolysis strips, gluconate, acetamide, 
and C.O.T. tablets were purchased from Key Scientific 
Products Co. (Los Angeles, Calif.). Antimicrobial discs were 
purchased from Difco. 
Tests for indole production, pigment production, 
growth on SS agar, growth at 42C, and antimicrobial suscepti-
bility testing were performed on media prepared by the author. 
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Pseudomonas aeruginosa ATCC 27853 was run as a control with 
all tests. Procedures used in performing and interpreting 
these tests are given on pages 61-65. 
III. RESULTS 
Biochemical and Physical Characterization 
One hundred and thirty-seven isolates were identified 
and found to belong to the following species: Pseudomonas 
aeruginosa (118), Ps. putida (5), Ps. fluorescens (1), 
Ps. stutzeri (1), three different isolates of Pseudomonas sp., 
Alcaligenes faecalis (4), Achromobacter sp. biotype II (4), 
and Acinetobacter anitratus (1) (Tables 3-7). The results 
obtained on species which contain a single isolate are self-
evident and will not be discussed further. 
All 118 strains of Ps. aeruginosa tested positive for 
arginine, oxidase, and growth at 42C. Ninety to 99% of the 
strains of this group gave positive results for xylose, 
aerobic-dextrose, urease, citrate, growth on SS, gelatin 
hydrolysis, gluconate, and arabinose. Negative reactions 
were demonstrated by all strains for anaerobic-dextrose, 
H2S, indole, ONPG, and lactose. Ninety-three percent of 
all strains gave negative reactions for rhamnose. 
The five strains of Ps. putida showed positive reactions 
for arginine dihydrolase, xylose, aerobic-dextrose, citrate, 
oxidase, arabinose, and growth on SS. All five demonstrated 
a negative reaction for anaerobic-dextrose, nitrogen gas, 
H2S, indole, pigment production, ONPG, gelatin hydrolysis, 
maltose, lactose and growth at 42C. 
12 
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All four isolates identified as Alcaligenes faecalis 
gave positive reactions to nitrogen gas, acetamide, and 
growth at 42C. All were negative for anaerobic-dextrose, 
arginine, H2s, indole, xylose, aerobic-dextrose, urease, 
pigment, ONPG, gluconate, fructose, maltose, mannitol, 
lactose and rhamnose. 
All four strains of Achromobacter sp. biotype II were 
positive for urease, growth on SS, gelatin hydrolysis, 
arabinose, and growth at 42C. All four strains were nega-
tive for anaerobic-dextrose, rr2s, indole, pigment production, 
ONPG, gluconate, lactose and rhamnose. 
Antimicrobial Characterization 
There was no antimicrobial agent tested which was 
effectlve against all 118 strains of Pseudomona! aeruginosa. 
Ninety to 99% of these strains were susceptible to polymyxin 
B, gentamicin, and tobramycin. Ninety-four strains (80%) 
were susceptible and twenty strains (17%) were intermediate 
in their reaction to carbenicillin. All strains demonstrated 
resistance to penicillin, nitrofurantoin, lincomycin, and 
cephalothin. Resistance to tetracycline, kanamycin, ampi-
cillin, nalidixic acid, streptomycin, chloramphenicol, and 
erythromycin was evident in 90% to 99% of the strains of Ps. 
aerugin~~· Eighty percent of the strains were susceptible, 
while 16% gave intermediate reactions to gantrisin, a sulfa 
drug. 
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All strains (5) of Pseudomonns putida were susceptible 
to polymyxin B and tobramycin. Four of the five isolates 
studied were susceptible to neomycin. An intermediate 
reaction was shown by SO% of the strains to gentamicin. 
All strains were resistant to gantrisin, penicillin, ampi-
cillin, nalidixic acid, nitrofurantoin, lincomycin, erythro-
mycin, and cephalothin. 
The four strains of Alcaligenes faecalis showed sus-
ceptibility to nitrofurantoin. Seventy-five percent of the 
strains demonstrated susceptibility to gentamicin, tobra-
mycin, and carbenicillin. All were resistant to penicillin, 
streptomycin, and lincomycin. 
The four isolates identified as Achromobacter sp. 
biotype II showed complete susceptibility to gentamycin, and 
tobramycin. Three strains (75%) were susceptible to poly-
myxin B, and streptomycin. All were resistant to penicillin, 
ampicillin, lincomycin, and cephalothin. Resistance to 
gantrisin, tetracycline, nalidixic acid, nitrofurantoin 
and erythromycin was demonstrated by 75% of this group. 
IV. DISCUSSION 
Biochemical and Physical Characterization 
A number of investigators (Starrier et al., 1966; 
Gilardi, 1968b; Pickett and Pedersen, 1970; Gilardi, 197la, 
197lb; Hugh and Gilardi, 1974; and Oberhofer et al., 197'1) 
have studied the biochemical activities of Pseudomonas 
aeruginosa and other pseudomonads. The studies of Gilardi 
(197la), Hugh and Gilardi (1974) and Oberhofer et al. (1977), 
as the most recent or most comprehensive studies, have been 
chosen for comparison with the present investigation (Ta-
bles 8-17). The results of such research and those of the 
present investigation were combined and the percentage of 
positive tests calculated to give the figures indicated in 
the two bottom rows of each table. As shown in the foot-
notes some tests were not performed on all isolates. Micro-
biologists, by convention, have accepted attributes char-
acterizing 90% or more of a certain bacterial species as 
"constant," typifying a certain species. 
Some characteristics of Ps. aeruginosa are remarkably 
constant, being positive or negative 90% or more of the time. 
These tests include: negative anaerobic-dextrose, H2s, 
indole, ONPG, maltose, lysine decarboxylase, and positive 
argine dihydrolase, xylose, aerobic-dextrose, citrate, 
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oxidase, growth on SS, gluconate, arabinose, and growth 
at 42C. Other features are variable and some of them at 
least are probably dependent on the substrate used, cultural 
and incubation conditions, and kind of medium. An example 
of this kind of variability is evident in the hydrolysis 
of gelatin where results are either positive or negative 
depending upon incubation period (two to seven days), incu-
bation temperature (22C compared with 37C), and the method 
used. Constant features which characterize Ps. aeruginosa 
are listed in Table 8. 
Ps. putida exhibits a high degree of consistency in 
its reaction to a number of biochemical tests (Table 9). 
Negative tests include nitrogen gas, H2S, indole, pigment, 
ONPG, gelatin hydrolysis, acetamide, growth at 42C, and 
lysine decarboxylase. Positive tests are arginine dyhydro-
lase, xylose, aerobic-dextrose, citrate, oxidase, growth 
on SS, fructose, and arabinose. Biochemically Ps. putida 
shows a strong relationship to Ps. aeruginosa but may be 
distinguished from it by the combined characteristics of 
a negative nitrogen gas test, absence of a pigment, inability 
to hydrolyze gelatin or grow at 42C. 
Anaerobic-dextrose, nitrogen gas, H2S, indole, pigment 
production, ONPG, acetamide, arabinose, growth at 42C, and 
lysine decarboxylase are negative tests while argine dihy-
drolase, xylose, aerobic-dextrose, citrate, oxidase, growth 
on SS, gelatin hydrolysis, and fructose are positive tests 
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wh.ich are typical and constant for 90% or more of Ps. fluo-
rescens strains (Table 10). Ps. fluorescens resembles Ps. 
putida and Ps. aeruginosa in the biochemical tests of the 
OxifFerm Tube (the first nine tests in Tables 8-18) but may 
be distinguished from Ps. putida by a pattern: positive 
gelatin hydrolysis, negative acetamide, and negative arabi-
nose. From Ps. aeruginosa it may be distinguished by its 
inability to produce nitrogen gas, utilize acetamide, 
arabinose, or grow at 42C. 
Table 11 compares results for Ps. stutzeri. Most 
strains are arginine dihydrolase negative, but otherwise 
the organism gives similar biochemical results on the Oxi/ 
Ferm Tube to Ps. aeruginosa, Ps. putida, and Ps. fluorescens. 
Tests useful in its identification are negative gelatin 
hydrolysis, gluconate, acetamide, and ability to grow at 
42C. 
Ps. cepacia, Ps. maltophilia, Ps. diminuta, Ps. alcali-
genes, Ps. pseudoalcaligenes, and Ps. putrefaciens were not 
encountered in this study. Since these species occur in 
clinical material they are included for comparison with 
other pseudomonads. 
The combined results of tests run on 60 strains of 
Ps. cepacia are given in Table 12. This species may be 
identified by the following tests: negative arginine 
dihydrolase, no growth on SS, positive ONPG and lactose and 
the ability to decarboxylate lysine. 
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The single most important attribute that characterizes 
93% of Ps. maltophilia strains is a negative oxidase test. 
Additional tests useful in its identification are given in 
Table 13, and include the ability to hydrolyze gelatin, 
utilize maltose and decarboxylate lysine. All strains tested 
to date are gluconate negative. Eighty-three percent are 
ONPG positive. 
Only 19 strains of Ps. diminuta have been investigated. 
Table 14 indicates that this organism is quite inert bio-
chemically except for the ability of 79% of the strains to 
hydrolyze gelatin. It is oxidase positive and can grow at 
42C. 
Strains of Ps. alcal~enes also seem to be inert bio-
chemically except for a small percent that gives a positive 
reaction for arginine dihydrolase, urease, citrate, and 
gelatin hydrolysis. Typical of most pseudomonads, it is 
oxidase positive, 86% can grow at 42C and a small number 
(10%) can grow on SS. Not evident in Table 15 is the alkini-
zation of xylose and aerobic-dextrose, a diagnostic feature 
of this species. 
Ps. pseudoalcaligenes (Table 16) may easily be confused 
with Ps. alcaligenes. Fructose, however, is utilized by 
the former and therefore may be used to distinguish the 
species. 
Table 17 shows test results for Ps. putrefaciens. The 
single most important and unique characteristic feature is 
H2S production. 
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A11timicrobial Characterization 
A number of investigators (von Graevenitz and Redys 
1968; Pedersen et al. 1970; Gilardi l97lc; Moody et al. 
1973, and more recently Oberhofer et al. 1977) have studied 
the antimicrobial susceptibility patterns of various pseudo-
monads. All these investigators used the Bauer-Kirby agar 
disk diffusion technique on Mueller-Hinton medium. It 
should be pointed out that some antibiotics were tested by 
some but not others; some reported their results in terms of 
S (Susceptible) and R (Resistant) whereas others used I 
(Intermediate) or E (Equivocal) to report a third category. 
The total number of strains studied was indicated by each 
investigator. In most cases percent susceptibility was 
given without any indication of the percentage of strains 
which were I, E, or R. Gilardi (l97lc) reported percent 
susceptibility which included strains giving Intermediate 
reactions. For this reason results from his study were not 
included when a combined percentage of strains susceptible 
was calculated, except in the case of Ps. putrifaciens 
(Table 28) where his study is the only one that appears in 
the literature. The results of such research and those of 
the present investigation were combined and the percentage 
of positive tests calculated to give the figures indicated 
in the two bottom rows of Tables 19-29. It is evident from 
these tables that some antimicrobial substances were not 
tested either because they were not considered important 
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by that particular investigator or because such an anti-
microbial was not available at the time. It should also be 
remembered that the reaction to an antimicrobial by a cer-
tain organism may not remain constant because of the emer-
gence of resistance. The use of the antibiogram as an aid 
in identification must therefore be used cautiously and must 
always be compared with a baseline study to determine if 
resistance is emerging in that particular community. 
Table 19 indicates that the majority of the strains of 
Ps. aeruginosa are susceptible to gentamicin, tobramycin, 
and polymyxin B. It is of interest to note that in the 
present investigation as well as that of Oberhofer et al, 
(1977), 80% to 82% of the strains are susceptible to car-
benicillin. Resistance to carbenicillin is on the rise. 
When carbenicillin was introduced four years ago Ps. aerugi-
nosa strains in the Stockton community were uniformly sen-
sitive to this antibiotic (F.M. Nahhas, personal communica-
tion). 
Table 20 indicates that the majority of Ps. putida 
strains are still susceptible to polymyxin B. Eighty-four 
percent are susceptible to kanamycin but only 69% are sen-
sitive to gentamicin. 
The antibiogram pattern of Ps. fluorescens (Table 21) 
shows the organism to have a similar antibiogram to that 
of Ps. putida with respect to polymyxin B, kanamycin, and 
gentamicin. Only the present study has investigated 
susceptibility to tobramycin but no conclusions should be 
made on the basis of a single strain. 
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Ps. stutzeri has a distinctive susceptibility pattern 
as evidenced in Table 22 which shows that in addition to 
susceptibility by the majority of the strains to the amino-
glycosides (gentamicin, tobramycin, kanamycin, neomycin and 
streptomycin), polymyxin nand carbenicillin, the organism 
shows susceptibility to ampicillin (80%), tetracycline (90%), 
erythromycin (96%), and nalidixic acid (85%). 
Only Oberhofer et al. (1977) studied the antibiogram 
pattern of Ps. cepacia (Table 23). This limited study 
(seven strains) indicates a 100% susceptibility to chloram-
phenicol and naladixic acid and relative resistance to the 
aminoglycosides. If further studies confirm these results 
Ps. cepacia may also be found to have a distinctive antibiogram. 
Polymyxin B was not tested. 
Table 24 for Ps. maltophilia, based on a study of 161 
strains, suggests a characteristic pattern of relative 
resistance to the aminoglycosides and susceptibility to 
polymyxin B (96%), nalidixic acid (94%), and chloramphenicol 
(83%). The pattern is similar to that of Ps. cepacia except 
that in the latter reaction to polymyxin B is not known. 
Table 25 is based on 21 strains of Ps. diminuta. The 
organism shows susceptibility to most of the aminoglycosides 
(gentamicin 89%, kanamycin 93%, neomycin 100%), 100% sus-
ceptibility to carbenicillin and chloramphenicol, 90% 
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susceptibility to tetracycline, and 92% to erythromycin. 
Table 26 is based on 19 strains of Ps. ~lcaligenes. 
The organism shows 100% susceptibility to kanamycin, carbeni-
cillin, tetracycline, and erythromycin, 86% to gentamicin, 
84% to chloramphenicol, and 89% to nalidixic acid. 
Ps. pseudoalcaligenes ('rable 27), based on 51 strains, 
shows a pattern similar to that of Ps. alcaligenes except 
for 100% susceptibility to gentamicin and 61% to kanamycin. 
Table 28 for Ps. putrefaciens, represented by 12 strains, 
has been obtained from Gilardi (197lc). A distinctive anti-
biogram pattern is seen in its susceptibility to nitrofuran-
toin. However, as indicated earlier in the discussion 
Gilardi (l97lc) combined the categories of Intermediate and 
Susceptible. 
V. CONCLUSION 
The present study indicates that a few biochemical tests 
in combination with an antibiogram may be used in the identi-
fication of the ten most commonly occurring pseudomonads. 
Tables 18 and 29 give summaries of the biochemical activi-
ties and antibiogram pattern, respectively, of the ten most 
common pseudomonads. It is clear from these tables that 
some of the biochemical tests and antibiotics are not es-
sential for identification. A modified scheme that combines 
a few biochemical tests and antimicrobial agents is here 
presented. This scheme suggests the use of a modified 
OxifFerm Tube to exclude the indole and urease tests. 
Indole and urease do not seem to be essential in identifica-
tion of pseudomonads. The additional tests recommended 
include oxidase, growth on SS, ONPG, gelatin hydrolysis, 
gluconate, and growth at 42C. In some instances confirma-
tory tests are essential. These appear under "Remarks" in 
Table 30. The antimicrobial disks recommended for the 
scheme include carbenicillin, ampicillin, erythromycin, and 
nalidixic acid. There are at least two characteristics 
that distinguish one species from another according to this 
scheme. 
Ps. aeruginosa, Ps. £!:1tida, and Ps. fluorescens (the 
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fluorescent group) are distinguished from the other seven 
species chiefly by their ability to dehydrolyze arginine. 
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Ps. aeruginosa according to this study, and several 
others cited earlier, is the most common pseudomonad in 
clinical material. It may be distinguished from Ps. putida 
and Ps. fluorescens by its ability to produce nitrogen gas, 
grow at 42C, and its sensitivity to carbenicillin. 
Ps. putida is very similar to Ps. fluorescens and the 
two species were considered conspecific by earlier investi-
gators. The studies reported in this paper, however, indi-
cate that Ps. putida may be distinguished from Ps. fluroescens 
by its inability to hydrolyze gelatin and by being arabinose 
positive. 
Ps. stutzeri may be distinguished from the nonfluorescent 
group by its ability to produce nitrogen gas. It differs 
from Ps. cepacia by negative ONPG and lysine decarboxylase 
tests, and susceptibility to carbenicillin and ampicillin. 
Ps. cepaci~ and Ps. maltophilia are the only two pseudo-
monads capable of decarboxaylating lysine. Ps. maltophilia 
is predominantly oxidase negative. Most strains are also 
citrate and xylose negative. 
Ps. diminuta, Ps. alcaligenes, and Ps. pseudoalcaligenes 
are closely related biochemically. Seventy-nine percent of 
the strains of Ps. diminuta hydrolyze gelatin and 95% are 
resistant to nalidixic acid. P~. alcaligenes and Ps. pseudo-
alcaligenes are very similar but may be distinguished from 
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each other chiefly by oxidation of fructose and to a lesser 
extent by growth on SS. 
Ps. putrefaciens has the distinctive characteristic 
of producing hydrogen sulfide. 
VI. SUMMARY 
One hundred and thirty-seven strains of Gram-negative 
nonfermentative ba~illi were obtained from clinical materials 
from in-and-out patients from Dameron and St. Joseph's 
Hospitals in Stockton, California. The strains were identi-
fied by biochemical studies, growth characteristics, and 
their antibiogram patterns determined by the Bauer-Kirby 
agar disk diffusion technique. Ps. aeruginosa, was represented 
by 118 strains (86.1%), Ps. putida five (3.6%), and one 
strain each of Ps. fluorescens and Ps. stut~eri (1.5%). 
Three other pseudomonads (2.0%) could not be identified to 
the species level. In addition to the pseudomonads four 
isolates (2.9%), were identified as Alcaligenes faecalis, 
four (2.9%), Achromobacter sp. biotype II, and one Acineto-
bacter anitratus (1.0%). 
The four species of pseudomonads encountered in this 
study with six others (Ps. cepacia, Ps. maltophilia, Ps. 
diminuta, Ps. alcaligene~, Ps. ~eudoalcaligenes, and Ps. 
12utrefaciens) were compared through literature search, and 
a scheme for their identification is presented. 
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Clinical 
Site 
Urine 
Upper Respira-
tory Tract 
Lower Respira-
tory Tract 
Burns 
Ear 
Wound 
Cervix 
Cerebrospinal 
Fluid 
Groin Incision 
Unknown 
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Distribution of Isolates in 
Clinical Material 
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Table 2 
Antimicrobial Disk Interpretation 
Inhibition Zone Diameter to Nearest mm 
Disc Resistant Intermediate Sensitive 
Potency mm or less mm range mm or more 
Polymyxin B 300 u 8 9-ll 12 
Gentamicin 10 ug 12 13 
Tobramycin 10 ug ll 10-ll 14 
Neomycin 30 ug 12 13-16 17 
Carbenicillin 100 ug 13 14-16 17 
Gantrisin 300 ug 12 13-16 17 
Penicillin 10 u 11 12-21 22 
Tetracycline 30 ug 14 15-18 19 
Kanamycin 30 ug 13 14-17 18 
Ampicillin 10 ug 11 12-13 14 
Nalidixic Acid 30 ug 13 14-18 19 
Nitrofurantoin 300 ug 14 15-16 17 
Streptomycin 10 ug ll 12-14 15 
Chloramphenicol 30 ug 12 13-17 18 
Lincomycin 2 ug 9 10-14 15 
Erythromycin 15 ug 13 14-17 18 
Cephalothin 30 ug 14 15-17 18 
Table 3a 
Biochemical and Physical Characteristics of the 
Pseudomonads Encountered in this Study 
Ps. Ps. Ps. Ps. Ps. sp. 1 Ps. sp. 2 Ps. sp. 3 
aerug:inosa out ida _fluorescens stutzeri 
(118) (5) (1) (1) (1) (1) (1) 
Anaerobic-Dextrose 0 0 0 0 0 0 0 
Arginine Dihydrolase 100 100 0 0 100 100 0 
Nitrogen Gas 64 0 0 100 0 0 0 
H2S 0 0 0 0 0 0 0 
Indole 0 0 0 0 0 0 0 
Xylose 96 100 0 100 0 0 0 
Aerobic-Dextrose 99 100 100 100 0 0 0 
Urease 92 80 100 0 0 0 100 
Citrate 99 100 100 100 100 0 0 
Oxidase 100 100 100 100 0 0 100 
Pigment (Pyocyanin) 83 0 0 0 0 0 0 
Growth on SS 97 100 100 100 100 0 100 
ONPG 0 0 0 0 0 0 0 
Gelatin Hydrolysis 96 0 100 0 0 100 0 
Gluconate 97 60 100 0 0 100 0 
Acetamide 82 20 0 0 0 100 100 
Fructose 56 so 0 100 0 0 0 
Maltose 11 0 0 0 0 0 0 
Mannitol 77 20 0 0 0 0 0 
Arabinose 96 100 0 0 0 100 0 
Lactose 0 0 0 0 0 0 0 
Rhamnose 7 40 0 0 i 0 0 0 
Growth at 42C 100 0 0 0 0 0 100 
a=Numbers in parentheses represent number of strains. Numbers in columns indicate percent positive. 
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Table 4a 
Comparison of Characteristics Among Strains 
of Ps. putida, Alcaligenes faecal is r.nd 
Achromobacter sp. biotype II 
Pseudomonas Alcaligenes Achromobacter 
put ida faecal is sp. biotype II 
A B c D E A B c D A B c D 
Anaerobic-Dextrose 
Arginine Dihydrolase + + + + + + + + 
Nitrogen Gas + + + + + + + 
u2s 
Indole 
Xylose + + + + + + + 
Aerobic-Dextrose + + + + + + + + 
Urease + + + + + + + + 
CHrate + + + + + + + + + 
Oxidase + + + + + + + + + + + 
Pigment (Pyocyanin) 
Growth on ss + + + + + + ~ + + + + + 
ONPG 
Gelatin Hydrolysis + + + + + + 
Gluconate + + + 
Acetamide + + + + + + 
Fructose + + + + + 
Maltose + 
Mannitol + + 
Arabinose + + + + + + + + + + + 
Lactose 
Rhamnose + + 
Growth at 42C + + + + + + + + 
a=Positive reaction,+; negative reaction,-. 
'fable 5a 
Biochemical and Physical 
Characteristics 
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Alcaligenes Achromobacter Acinetobacter 
faecal is sp. biotype II anitratus 
(4) ( 4) ( l) 
Anaerobic-Dextrose 0 0 0 
Arginine Dihydrolase 0 75 0 
Nitrogen Gas 100 75 0 
H2 S 0 0 0 
Indole 0 0 0 
Xylose 0 50 100 
Aerobic-Dextrose 0 75 100 
Urease 0 100 100 
Citrate 25 75 100 
Oxidase 75 75 0 
Pigment (Pyocyanin) 0 0 0 
Growth on SS 50 100 0 
ONPG 0 0 0 
Gelatin Hydrolysis 50 100 0 
Gluconate 0 0 0 
Acetamide 100 25 100 
Fructose 0 25 0 
Maltose 0 25 0 
Mannitol 0 25 0 
Arabinose 50 100 100 
Lactose 0 0 0 
Rhamnose 0 0 0 
Growth at 42C 100 100 100 
a~Numbers in parentheses indicate number of strains. Numbers 
in columns indicate percent positive. 
Anti microbia 1 
Polymyxin B 
Gentamicin 
Tobramycin 
Neomycin 
Carbenicillin 
Gantrisin 
Penicillin 
Tetracycline 
Kanamycin 
Ampicillin 
Nalidixic Acid 
Nitrofurantoin 
Streptomycin 
Chlormphenicol 
Lincomycin 
Erythromycin 
Cephalothin 
Pseudomonas 
aerug1nosa (118) 
S I R 
99 1 0 
95 0 5 
94 4 2 
a 36 ss 
80 17 3 
4 16 80 
0 0 100 
2 1 97 
1 1 98 
0 99 
0 1 99 
0 0 100 
2 1 97 
0 4 96 
0 0 100 
0 1 99 
0 0 100 
Table 61\. 
Antibiograms of the Pseudomonads 
Pseudomonas 
P(~)da 
S I R 
100 0 0 
0 80 20 
100 0 0 
80 20 0 
40 20 40 
0 0 100 
0 0 100 
20 40 40 
60 0 40 
0 0 100 
0 0 100 
0 0 100 
40 40 20 
0 40 60 
0 0 100 
0 0 100 
0 0 100 
s I R 
100 0 0 
100 0 0 
100 0 0 
100 0 0 
0 0 100 
0 0 100 
0 0 100 
0 100 0 
100 0 0 
0 0 100 
0 100 0 
0 0 100 
100 0 0 
0 0 100 
0 0 100 
0 0 100 
0 0 100' 
Pseudomonas 
stutzen 
(1) 
S I R 
100 0 0 
100 0 0 
100 0 0 
100 0 0 
100 0 0 
0 0 100 
0 0 100 
100 0 0 
0 0 100 
100 
0 
0 
100 
0 
0 0 
0 100 
0 100 
0 0 
0 100 
0 0 100 
0 100 0 
0 0 100 
Pseudomonas 
Sp. 1 
(1) 
S I R 
100 0 0 
100 0 0 
100 0 0 
100 0 0 
100 0 0 
0 100 0 
0 100 0 
0 100 0 
100 0 0 
100 0 0 
0 100 0 
0 0 1 DO 
0 0 100 
0 0 100 
0 0 100 
0 100 0 
0 0 100 
Pseudomonas 
Sp. 2 
(1) 
S I R 
100 0 0 
100 0 0 
100 0 0 
100 0 0 
100 0 0 
100 0 0 
0 0 100 
0 100 0 
100 0 0 
0 0 100 
0 100 0 
0 0 100 
0 0 100 
0 0 100 
0 0 100 
0 100 0 
0 0 100 
a=Numbers in each column indicate percent Susceptible (S); Intermediate (I); or Resistant (R). 
Numbers in parentheses indicate number of strains 
Pseudomonas 
Sp. 3 
(1) 
S I R 
100 0 0 
100 0 0 
100 0 0 
100 0 0 
100 0 0 
0 0 100 
0 0 100 
0 0 100 
0 100 0 
0 0 100 
0 0 100 
0 0 100 
0 100 0 
0 0 100 
0 0 100 
0 0 100 
0 0 100 
w 
"' 
1 
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1 Table 7a 
Antibiograms of Alcalig£ne~ faecalis 
1 Achromobacter Sp. biotype II and 
-----Acinetobacter anitratus 
1 
Alcaligenes Achromobacter Acinetobacter 
faeca1is sp. biotype!! anitratus 
---rrr- (4) ( 1 ) 
Antimicrobial s I R s I R s I R 
Polymyxin B 50 25 25 75 0 25 100 0 0 
Gentamicin 75 0 25 100 0 0 100 0 0 I I 
Tobramycin 75 0 25 100 0 0 100 0 0 I 
Neomycin 25 25 50 50 25 25 100 0 0 l 
Carbenicillin 75 0 25 50 0 50 0 100 0 I 
I Gantrisin 25 0 75 25 0 75 0 0 100 I 
Penicillin 0 0 100 0 0 100 0 0 100 
' 1 
Tetracycline 50 0 50 25 0 75 0 100 0 
Kanamycin 25 0 75 50 0 50 100 0 0 1 
f,rnpicillin 25 0 75 0 0 100 0 0 100 
Nalidixic Acid 50 0 50 25 0 75 0 100 0 
Nitrofurantoin 100 0 0 25 0 75 0 0 100 
Streptomycin 0 0 100 75 0 25 0 0 100 
Chloramphenicol 25 25 50 50 0 50 100 0 0 l 
I 
Lincomycin 0 0 100 0 0 100 0 0 100 l 
Erythromycin 25 25 50 25 0 75 0 0 100 I I 
Cephalothin 25 0 75 0 0 100 0 0 100 
1 
a=Numbers in each column indicate percent Susceptible (S); 
1 
Intermediate (I); or Resistant (R). Numbers in parentheses 
indicate number of strains. 
1 
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Table 8* 
1 Summary of Biochemical and Physical 
Characteristics of~· aeruginosa 
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1 Anaerobic Dextrose 0 0 0 0 0/375 0 
Arginine Dihydrolase 118 91 117 48 374/375 99 
1 
Nitrogen gas 76 87 lll 30 304/375 81 
H2S 0 0 0 0 0/312 0 
Indole 0 0 NT NT 0/209 0 
1 Xylose 113 96 118 43 361/375 96 
Aerobic Dextrose 117 91 118 48 374/375 99 
' 1 Urease 109 63 27 43 242/375 65 
Citrate 117 87 118 NT 322/323 99 
1 
Oxidase 118 91 118 48 375/375 100 
Pigment (Pyocyanin) 98 72 68 NT 238/327 72 
Growth on SS 114 84 51 47 296/312 95 
1 ONPG 0 3 0 0 3/312 1 
Gelatin Hydrolysis 113 73 117 29 332/375 89 
1 G1uconate 114 82 118 35 349/375 93 
Acetamide 97 85 NT NT 182/205 89 
1 Fructose 66 (62) 107 46 281/375 75 
Naltose 13 0 0 0 13/375 3 
Mannitol 91 (63) 109 34 297/375 79 
1 Arabinose 113 NT 118 NT 231/236 98 
Lactose 0 0 (41) 0 41/375 11 
1 Rhamnose 8 NT (90) 15 113/284 40 
Growth at 42C 118 NT 118 48 284/284 100 
1 Lysine Decarboxylase NT 0 0 0 0/257 0 
~=Numbers in each column indicate number of positive strains. NT signifies 
1 
not tested. Parentheses indicate percent positive, delayed 3 or more days. 
1 
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Table 9* 
Summary of Biochemical and Physical 
Characteristics of fl. eutida 
"0 
·~ <lJ 
~ u ..... 
"' 
,_ 
"' 
"' 
u <lJ 
..... ~ ~~ ~ 1-
<lJN ·~N 
" "" >., LO t!l" (J) ....... <lJ 
u s...~ ~ ~ <lJ > 
"' 
<lJ 
" 
~ > ·~ 
..... '>-" C<T ·~a •r• ..... (/)~ or-.. 
"'" 
TJM ..... ·~ 
LO ..<:: (J) 0'\ s...~ ·~ 
"' '"~ s...~ ..c ~ "' "' 0 ·~ <lJ Ol ~ 0 a.. 
..c: .n 
"' 
·~ a.. 1- 0 ::r: t!l 
""' 
w 
Anaerobic Dextrose 0 0 0 0 0/159 0 
Arginine Dihydrolase 5 52 70 30 157/159 99 
Nitrogen gas 0 0 0 0 0/159 0 
H2S 0 0 0 0 D/159 0 
Indole 0 0 NT NT 0/57 0 
Xylose 5 50 69 29 153/159 96 
Aerobic Dextrose 5 52 72 30 159/159 100 
Urease 4 6 37 19 66/159 42 
Citrate 5 52 NT NT 57/57 100 
Oxidase 5 52 72 30 159/159 100 
Pigment (Pyocyanin) 0 0 0 NT 0/129 0 
Growth on SS 5 49 72 30 156/159 98 
ONPG 0 0 1 0 1/159 1 
Gelatin Hydrolysis 0 0 0 0 0/159 0 
Gluconate 3 41 53 22 119/159 75 
Acetamide 1 3 NT NT 4/57 7 
Fructose 4 (49) 71 29 153/159 96 
Maltose 0 0 25 7 32/159 20 
Mannitol 1 (8) 14 6 29/159 18 
Arabi nose 5 NT NT NT 5/5 100 
Lactose 0 0 20 6 26/159 16 
Rhamnose 2 NT 45 18 65/1 07 61 
Growth at 42C 0 NT 0 0 0/107 0 
Lysine Decarboxylase NT 0 0 0 0/154 0 
*=Numbers in each column indicate number of positive strains. NT signifies 
not tested. Parentheses indicate percent positive, delayed 3 or more days. 
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Table 10* 
Summary of Biochemical and Physical 
Characteristics of Ps. fl uorescens 
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Anaerobic Dextrose 0 0 0 0 0/81 0 
Arginine Dihydrolase 0 18 49 12 79/81 98 
Nitrogen gas 0 0 l 0 l/81 1 
H2S 0 0 0 0 0/81 0 
Indole 0 0 NT NT 0/19 0 
Xylose 0 16 49 12 77/81 95 
Aerobic Dextrose 1 18 50 12 81/81 100 
Urease 1 4 20 11 36/81 44 
Citrate 1 18 NT NT 19/19 100 
Oxidase 1 18 50 12 81/81 100 
Pigment (Pyocyanin) 0 0 0 NT 0/69 0 
Growth on SS 1 16 49 11 77/81 95 
ONPG 0 0 2 0 2/81 2 
Gelatin Hydrolysis l 17 50 12 80/81 99 
Gluconate 1 10 35 8 54/81 67 
Acetamide 0 1 NT NT l/19 5 
Fructose 0 (15) 49 11 75/81 93 
Maltose 0 0 35 10 45/81 56 
Mannitol 0 (3) 47 10 60/81 74 
Arabinose 0 NT NT NT 0/l 0 
Lactose 0 l 13 l 15/81 19 
Rhamnose 0 NT 42 9 51/63 81 
Growth at 42C 0 NT 0 0 0/62 0 
Lysine Decarboxylase NT 0 0 0 0/80 0 
*"Numbers in each column indicate number of positive strains. NT signifies 
not tested. Parentheses indicate percent positive, delayed 3 or more days. 
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Table 11* 
Summary of Biochemical and Physical 
Characteristics of Ps. stutzeri 
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Anaerobic Dextrose 0 0 0 0 0/85 0 
Arginine Dihydrolase 0 10 0 0 10/85 12 
Nitrogen gas 1 13 45 24 83/85 98 
H2S 0 0 0 0 0/85 0 
Indole 0 0 NT NT 0/16 0 
Xylose 1 ( 15) 45 24 85/85 100 
Aerobic Dextrose 1 15 45 24 85/85 100 
Urease 0 8 12 5 25/85 29 
Citrate 13 NT NT 14/16 88 
Oxidase 1 15 45 24 85/85 100 
Pigment (Pyocyanin) 0 0 0 NT 0/61 0 
Growth on SS 1 13 (40) 22 76/85 89 
ONPG 0 0 0 0 0/85 0 
Gelatin Hydrolysis 0 0 0 0 0/85 0 
G1uconate 0 0 1 0 1/85 1 
Acetamide 0 2 NT NT 2/16 1 
Fructose 1 ( 12) 45 24 82/85 96 
Maltose 0 ( 13) 14 24 51/85 60 
Mannitol 0 (9) 40 21 70/85 82 
Arabinose 0 NT NT NT 0/1 0 
Lactose 0 0 0 0 0/85 0 
Rhamnose 0 NT 32 18 50/70 71 
Growth at 42C 0 NT 45 24 69/70 99 
Lysine Decarboxylase NT 0 0 0 0/84 0 
*~Numbers in each column indicate number of positive strains. NT signifies 
not tested. Parentheses indicate percent positive, delayed 3 or more days. 
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Table 12* 
Summary of Biochemical and Physical 
Characterist·ics of Ps .. ~epacia 
"' ·~ (]J 
~ 
"' 
+> 
"' 
s.. Ul 
"' 
u (]J 
+> ~~ ~ 1-
(]J~ ·~~ ..... 
"" 
(]J 
..... 
'"' <1" 
()) 
' 
> s..~ ~ ~ (J) ·~ (]J 
"' 
~ > +' 
......... <::<1" ·~N ·~ ·~ or--. "' ..... -o~ +> Ul 
.c Q) Q) s..~ ·~ 0 s..~ .c ~ 
"' 
Ul c.. (]J Ol ~ 0 
.0 ::J ·~ c.. 
"" 0 :r: 
'"' 
"~ 
Anaerobic Dextrose 0 0 0 0/60 0 
Arginine Dihydrolase 0 0 0 0/60 0 
Nitrogen gas 0 0 0 0/60 0 
H2S 0 0 0 0/60 0 
Indole 0 NT NT 0/7 0 
Xylose 6 41 12 59/60 98 
Aerobic Dextrose 7 41 12 60/60 100 
Urease 6 41 5 25/60 42 
Citrate sa NT NT S/S 100 
Oxidase s 37 10 S2/60 87 
Pigment (Pyocyanin) 0 0 NT 0/48 0 
Growth on SS 0 1 0 1/60 2 
ONPG 7 37 12 S6/60 93 
Gelatin Hydrolysis (7) 26 7 40/60 67 
Gluconate 4 s l 10/60 17 
Acetamide sa NT NT S/S 100 
Fructose 6 41 12 S9/60 98 
Maltose 6 41 12 S9/60 98 
t~annito l s 41 12 S8/60 97 
Arabinose NT NT NT NT NT 
Lactose 7 41 12 60/60 100 
Rhamnose NT 0 0 O/S3 0 
Growth at 42C NT 29 7 36/S3 68 
Lysine Decarboxylase 7 38 12 S7/60 9S 
*-Numbers in each column indicate number of positive strains. NT SlgnifleS 
not tested. Parentheses indicate percent positive, delayed 3 or more days. 
a = Five strains were tested. 
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Table 13* 
Summary of Biochemical and Physical 
Characteristics of Ps. !llaltophilia 
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Anaerobic Dextrose 0 0 0 0/356 0 
Arginine Dihydrolase 0 0 0 0(356 0 
Nitrogen gas 0 0 0 0/356 0 
H2S 0 0 0 0/356 0 
Indole 0 NT NT 0/80 0 
Xylose 2 l 03 45 150/356 42 
Aerobic Dextrose ll 195 81 287/356 81 
Urease 47 ob 0 47/169 28 
Citrate 62a 13 NT 75/263 29 
Oxidase 22 2 0 24/356 7 
Pigment (Pyocyanin) 0 0 NT 0/275 0 
Growth on SS 24 0 0 24/356 7 
ONPG 32 185 80 297/356 83 
Gelatin Hydrolysis 80 195 81 356/356 100 
Gluconate 0 0 0 0/356 0 
Acetamide (8)a NT NT 8/68 12 
Fructose 34 193 79 306/356 86 
Maltose 79 195 81 355/356 99 
Mannitol 0 0 0 0(356 0 
Arabinose NT NT NT NT NT 
Lactose 0 176 75 251/356 7l 
Rhamnose NT ob 0 0/122 0 
Growth at 42C NT 148 67 215/276 78 
Lysine Decarboxylase 80 195 81 276/276 100 
*-Numbers in each column indicate number of positive strains. NT signifies 
not tested. Parentheses indicate percent positive, delayed 3 or more days. 
a=Sixty-eight strains were tested. 
b=Forty-one strains were tested. 
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Table 14* 
Summary of Biochemical and Physical 
Characteristics of Ps. diminuta 
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Anaerobic Dextrose NT NT 0 0/4 0 
Arginine Dihydro1ase 0 0 0 0/19 0 
Nitrogen gas 0 0 0 0/19 0 
H2S 0 0 0 0/19 0 
Indole 0 NT NT 0/9 0 
Xylose NT 0 0 0/10 0 
Aerobic Dextrose NT 0 0 0/10 0 
Urease 0 NT 0 0/13 0 
Citrate 0 NT NT 0/9 0 
Oxidase 9 6 4 19/19 100 
Pigment (Pyocyanin) 0 NT NT 0/9 0 
Growth on SS 0 0 0 0/19 0 
ONPG 0 0 0 0/19 0 
Gelatin Hydrclysis (5) 6 4 15/19 79 
Gluconate 0 NT 0 0/13 0 
Acetamide 0 NT NT 0/9 0 
Fructose 0 0 0 0/19 0 
Maltose 0 0 0 0/19 0 
Mannitol 0 0 0 0/19 0 
Arabinose NT NT NT NT NT 
Lactose 0 0 0 0/19 0 
Rhamnose NT NT 0 0/4 0 
Growth at 42C NT 6 4 10/lO 100 
Lysine Decarboxylase 0 0 0 0/19 0 
·k=Numbers in each column indicate number of positive strains. NT signifies 
not tested. Parentheses indicate percent positive, delayed 3 or more days. 
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Table l5·k 
1 Summary of Biochemical and Physical Characteristics of Ps. alcaligenes 
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Anaerobic Dexttose NT 0 0 0/22 0 
1 Arginine Dihydrolase 7 0 0 7/30 23 
Nitrogen gas 0 0 0 0/30 0 
1 H2S 0 0 0 0/30 0 
Indo 1 e 0 NT NT 0/8 0 
1 
Xylose NT 0 0 0/22 0 
Aerobic Dextrose NT 0 0 0/22 0 
Urease 1 NT 1 2/15 13 
1 Citrate 2 NT NT 2/8 25 
Oxidase 8 15 7 30/30 100 
1 Pigment (Pyocyanin) 0 NT NT 0/8 0 
Gro11th on SS 3 0 0 3/30 10 
1 
ONPG 0 0 0 0/30 0 
Gelatin Hydrolysis 0 1 1 2/30 7 
G1uconate 0 NT 0 0/15 0 
1 Acetamide 0 NT NT 0/8 0 
Fructose 0 0 0 0/30 0 
1 Maltose 0 0 0 0/30 0 
Mannitol 0 0 0 0/30 0 
1 Arabinose NT NT NT NT NT 
Lactose 0 0 0 0/30 0 
Rhamnose NT NT 0 0/7 0 
1 Gro11th at 42C NT 12 7 19/22 86 
Lysine Decarboxylase 0 0 0 0/30 0 
1 *=Numbers in each column indicate number of positive strains. NT signffies 
not tested. Parentheses indicate percent positive, delayed 3 or more days. 
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Table 16* 
Summary of Biochemical and Physical 
Characteristics of Ps. Q_seudoa l cal i genes 
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Anaerobic Dextrose NT NT 0 0/6 0 
Arginine Dihydrolase 18 2 0 20/45 44 
Nitrogen gas 0 0 0 0/45 0 
H2S 0 0 0 0/45 0 
Indole 0 NT NT 0/25 0 
Xylose 1 14 3 18/45 40 
Aerobic Dextrose 7 13 6 26/45 58 
Urease 1 NT 0 l/31 32 
Citrate 8 NT NT 8/25 32 
Oxidase 25 14 6 45/45 100 
Pigment (Pyocyanin) 0 NT NT 0/25 0 
Growth on SS 16 12 5 33/45 73 
ONPG 0 0 0 0/45 0 
Gelatin Hydrolysis 0 0 0 0/45 0 
Gluconate 0 NT 0 0/31 0 
Acetamide 0 NT NT 0/25 0 
Fructose (24) 14 6 44/45 98 
Maltose 0 2 0 2/45 4 
Mannitol 3 0 0 3/45 7 
Arabinose NT NT NT NT NT 
Lactose 0 0 0 0/45 0 
Rhamnose NT NT 0 0/6 0 
Growth at 42C NT 13 6 19/20 95 
Lysine Decarboxylase 0 0 0 0/45 0 
*-Numbers in each column indicate number of positive strains. NT signifies 
not tested. Parentheses indicate percent positive, delayed 3 or more days. 
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Table 17* 
Summary of Biochemical and Physical 
Characteristics of Ps. eutrefaciens 
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Anaerobic Dextrose 0 0 0/22 0 
Arginine Dihydrolase 0 0 0/22 0 
Nitrogen gas 0 0 0/22 0 
H2S 16 6 22/22 100 
Indole NT NT NT NT 
Xylose 1 0 1/22 5 
Aerobic Dextrose 16 (6) 22/22 100 
Urease 4 3 7/22 32 
Citrate NT NT NT NT 
Oxidase 16 6 22/22 100 
Pigment (Pyocyanin) 0 NT 0/16 0 
Growth on SS 15 6 21/22 95 
ONPG 0 0 0/22 0 
Gelatin Hydrolysis 15 6 21/22 95 
Gluconate 0 0 0/22 0 
Acetamide NT NT NT NT 
Fructose 7 (3) 10/22 45 
Ma Hose 5 0 5/22 23 
f~annitol NT 0 0/6 0 
Arabinose NT NT NT NT 
Lactose 3 (2) 5/22 23 
Rhamnose 3 (2) 5/22 23 
Growth at 42C 16 6 22/22 100 
Lysine Decarboxylase 0 0 0/22 0 
*=Numbers in each column indicate number of positive strains. NT signifies 
not tested. Parentheses indicate percent positive, delayed 3 or more days. 
Table 18* 
Summary of Biochemical and Physical 
Characteristics of the Pseudomonads 
Anaerobic Dextrose 
Arginine Dihydrolase 
Nitrogen Gas 
H2S 
Indole 
Xylose 
Jl.erobic Dextrose 
Urease 
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0 23 44 0 
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13 
0 0 
0 100 
0 NT 
40 5 
58 100 
32 32 
Citrate 
99 100 100 100 100 
65 42 44 29 42 
99 1 00 1 00 88 1 00 29 0 25 32 NT 
Oxidase 100 100 100 100 87 
0 
2 
93 
7 l 00 100 1 00 1 00 
Pigment (Pyocyanin) 
Growth on SS 
ONPG 
Gelatin Hydrolysis 
G1uconate 
Acetamide 
Fructose 
Ma 1 tose 
Mannitol 
Arabinose 
Lactose 
Rhamnose 
Growth at 42C 
Lysine Decarboxylase 
72 0 0 0 
95 
1 
89 
93 
89 
98 
1 
0 
75 
7 
95 
2 
99 
67 
5 
89 
0 
0 
1 
1 
75 96 93 96 
3 20 56 60 
79 18 74 82 
0 
0 
7 
83 
67 100 
17 
100 
0 
12 
98 86 
98 99 
97 0 
NT 98 100 
11 16 
40 
100 
0 
61 
0 
0 
0 
19 
81 
0 
0 
0 100 
71 0 
NT 
71 
0 
99 
0 
68 78 
95 100 
*=Numbers in columns indicate percent positive. NT 
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0 
0 
0 
73 
0 
0 
0 
0 
0 
95 
0 
95 
0 
NT 
0 98 45 
0 4 23 
0 7 0 
NT NT NT NT 
0 0 0 23 
0 0 0 23 
l 00 86 95 100 
0 0 0 0 
s1gnifies not tested. 
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1 Table 19* 
Summary of Antibiograms of 
1 h· aeruginosa 
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1 Gentamicin 112 75 NT 187/203 92 
Tobramycin 111 NT NT 111/118 94 
1 Kanamycin 1 20 6 27/217 12 
Neomycin 9 NT 6 15/132 11 
1 Streptomycin 2 24 3 29/217 13 
Polymyxin B 117 NT NT 117/118 99 
1 
Carbenicillin 94 70 NT 164/203 81 
1 Ampici11 in 12 4 0 16/321 5 
Penicillin 0 NT NT 0/118 0 
1 Chloramphenicol 0 19 2 21/217 10 
Tetracycline 2 16 0 18/321 6 
1 Cephalothin 0 0 0 0/321 0 
Lincomycin 0 NT 0 0/132 0 
1 Erythromycin 0 NT 0 0/132 0 
Gantl'i sin 5 NT NT 5/118 4 
1 Nalidixic Acid 0 13 0 13/321 4 
Nitrofurantoin 0 0 NT 0/203 0 
1 
*=Numbers in each column indicate number of positive strains. NT signifies 
1 
not tested. Susceptibilities are not intended as a thertipeut i c guide but 
are used as supplemental data for identification. 
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Table 20* 
1 Summary of Antibiograms of 
h· ~utida 
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"" ""' l ..... Gentamicin 0 46 5 NT NT 51/74 69 
Tobramycin 5 NT NT NT NT 5/5 100 1 
Kanamycin 3 45 15 5 5 73/87 84 
1 Neomycin 4 NT 4 NT 5 13/27 48 
Streptomycin 2 36 0 NT 0 38/79 48 
' 1 
Polymyxin B 5 NT 16 NT NT 21/22 95 
Carbenicillin 2 0 0 NT NT 2/74 1 
1 Ampicillin 0 0 0 0 0 0/87 0 
Penicillin 0 NT NT NT NT 0/5 0 1 
Chloramphenicol 0 11 0 1 0 12/87 14 
1 Tetracycline 1 32 12 4 0 39/87 45 
Cephalothin 0 0 0 0 0 0/87 0 
1 Lincomycin 0 NT NT NT 0 0/10 0 
Erythromycin 0 NT NT NT 0 0/10 0 
1 Gantrisin 0 NT NT NT NT 0/5 0 
Nalidixic Acid 0 0 NT NT 0 0/62 0 1 
Nitrofurantoin 0 0 NT NT NT 0/57 0 
1 
*=Numbers in each column indicate number of positive strains. 
1 NT signifies not tested. Susceptibilities are not intended 
as a therapeutic guide but are used as supplemental data for 
1 identification. 
1 
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Table 21* 
Summary of Antibiograms of 
Ps. fl uorescens 
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Gentamicin l 17 7 NT 25(39 64 
Tobramycin l NT NT NT l(l 100 
Kanamycin l 17 90 10 37(39 95 
Neomycin l NT 50 NT 6(11 55 
Streptomycin l 13 20 NT 16/28 57 
Polymyxin B l NT 10 NT 11 Ill 100 
Carbenicillin 0 0 0 NT 0/28 0 
Jlmp i c ill in 0 0 0 NT 0/28 0 
Penicillin 0 NT NT NT 0/l 0 
Chloramphenicol 0 6 0 11 17/39 44 
Tetracycline 0 13 3 ll 27/39 69 
Cephalothin 0 0 0 9 9/39 23 
Lincomycin 0 NT NT NT 0/1 0 
Erythromycin 0 NT NT NT 0/l 0 
Gantrisin 0 NT NT NT 0/l 0 
Nalidixic Acid 0 5 NT NT 5/18 28 
Nitrofurantoin 0 0 NT NT 0/18 0 
*=Numbers in each column indicate number of positive strains. 
NT signifies not tested. Susceptibilities are not intended 
as a therapeutic guide but are used as supplemental data for 
identification. 
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Table 22* 
1 
Summary of Antibiograms of 
1 
Ps. stutzeri 
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Gentamicin 1 28 13 NT NT 42/40 100 
1 Tobramycin 1 NT NT NT NT l/1 100 
Kanamycin 0 28 6 13 25 72/81 89 
1 Neomycin 1 NT 9 NT 25 35/39 90 
Streptomycin 1 27 7 NT 24 59/67 88 
1 Polymyxin B 1 NT 13 NT NT 14/14 100 
Carbenici11 in 1 27 13 NT NT 41/42 98 
1 Ampicillin 1 25 6 8 25 65/81 80 
Penicillin 0 NT NT NT NT 0/1 0 
1 Chl oramphenico1 0 15 12 10 23 60/81 74 
Tetracycline 1 28 7 14 23 73/81 90 
1 Cephalothin 0 1 0 4 25 30/81 37 
Lincomycin 0 NT NT 0 0 0/26 0 
1 Erythromycin 0 NT NT NT 25 25/26 96 
Gantrisin 0 NT NT NT NT 0/1 0 
Nalidixic Acid 0 24 NT NT 22 46/54 85 
1 Nitrofurantoin 0 0 NT NT NT 0/29 0 
*=Numbers in each column indicate number of positive strains. 1 
NT signifies not tested. Susceptibilities are not intended 
1 as a therapeutic guide but are used as supplemental data for identification. 
1 
1 
Gentamicin 
Tobramycin 
Kanamycin 
Neomycin 
Streptomycin 
Polymyxin B 
Carbenicillin 
Ampici11 in 
Penicillin 
Chloramphenicol 
Tetracycline 
Cephalothin 
Lincomycin 
Erythromycin 
Gantrisin 
Nalidixic Acid 
Nitrofurantoin 
Table 23* 
Summary of Antibiograms of 
£'?..· ~a cia 
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7!7 
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*~Numbers in each column indicate number of positive strains. 
NT signifies not tested. Susceptibilities are not intended 
as a therapeutic guide but are used as supplemental data for 
identification. 
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Table 24 .. 
Summary of Antibiograms of 
Ps. maltophilia 
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Gentamicin 27 3 NT NT 30/97 31 
Tobramycin NT NT NT NT NT NT 
Kanamycin 11 2 5 28 46/161 29 
Neomycin NT 3 NT 28 31/59 53 
Streptomycin 18 2 NT 24 4~/132 33 
Polymyxin NT 23 NT NT 23/24 96 
Carbenicillin 14 4 NT NT 18/97 19 
Ampicillin 1 0 6 0 7/161 4 
Penicillin NT NT NT NT NT NT 
Chloramphenicol 56 19 24 35 134/161 83 
Tetracycline 23 3 20 24 70/161 43 
Cephalothin 1 0 0 26 27/161 17 
Lincomycin NT NT NT 0 0/35 0 
Erythromycin NT NT NT 26 26/35 74 
Gantrisin NT NT NT NT NT NT 
Nalidixic Acid 67 NT NT 35 102/1 08 94 
Nitrofurantoin 2 NT NT NT 2/73 3 
*=Numbers in each column indicate number of positive strains. 
NT signifies not tested. Susceptibilities are not intended 
as a therapeutic guide but are used as supplemental data for 
identification. 
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Table 25* 
Summary of Antibiograms of 
Ps. diminuta 
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Gentamicin 8 NT NT 8/9 89 
Tobramycin NT NT NT NT NT 
Kanamycin 8 NT 6 14/15 93 
Neomycin NT NT 6 6/6 100 
Streptomycin 2 NT 3 5/15 33 
Polymyxin B NT NT NT NT NT 
Carbenici11 in 9 NT NT 9/9 100 
Ampicillin 1 NT 0 l/9 11 
Penicillin NT NT NT NT NT 
Chloramphenicol 9 6 6 21/21 100 
Tetracyc 1 ine 9 5 5 19/21 90 
Cephalothin 5 NT 2 7/15 47 
Lincomycin NT NT 0 0/6 0 
Erythromycin NT 5 6 ll/12 92 
Gantrisin NT NT NT NT NT 
Nalidixic Acid 0 1 0 1/21 5 
N i trofut·<~nto in 0 NT NT 0/9 0 
*=Nur.Jbet·s in each column indicate number of positive strains. 
NT signifies not tested. Susceptibilities are not intended 
as a therapeutic guide but are used as supplemental data for 
identification. 
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Table 26* 
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Summary of Antibiograms of 
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Gentamicin 6 NT 6/7 86 
1 Tobramycin NT NT NT NT 
Kanamycin 7 12 19/19 100 
1 
Neomycin NT NT NT NT 
Streptomycin 2 NT 2/7 29 
Polymyxin B NT NT NT NT 
1 Carbenici 11 in 7 NT 7/7 100 
Ampicillin 1 6 7/19 37 
1 Penicillin NT NT NT NT 
Chloramphenicol 4 12 16/19 84 
1 Tetracycline 7 12 19/19 100 
Cephalothin 0 6 6/19 32 
1 Lincomycin NT NT NT NT 
Erythromycin NT 12 12/12 100 
1 Gantrisin NT NT NT NT 
Nalidixic Acid 7 10 17/19 89 
1 Nitrofurantoin 0 NT 0/7 0 
*=Numbers in each column indicate number of positive strains. 
1 NT signifies not tested. Susceptiblities are not intended 
as a therapeutic guide but are used as supplemental data for 
identification. 
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Table 27* 
1 Summary of Antibiograms of 
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Gentamicin 23 NT 23/23 100 1 
Tobramycin NT NT NT NT 
1 
Kanamycin 21 10 31/51 61 
Neomycin NT NT NT NT 
Streptomycin 15 NT 15/23 65 
1 Polymyxin B NT NT NT NT 
Carbenicillin 23 NT 23/23 100 
1 Ampicil1 in 14 14 28/51 55 
Penicillin NT NT NT NT 
1 Chloramphenicol 16 28 44/51 86 
Tetracycline 23 27 50/51 98 
Cephalothin 0 21 21/51 41 
1 Lincomycin NT NT NT NT 
Erythromycin NT 27 27/28 96 
1 Gantrisin NT NT NT NT 
Nalidixic Acid 21 22 43/51 84 
1 Nitrofurantoin 0 NT 0/23 0 
*=Numbers in each column indicate number of positive strains. 
1 NT signifies not tested. Susceptibilities are not intended 
as a therapeutic guide but are used as supplemental data for 
-ident i fi cat ion. 
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Table 28* 
Summary of Antibiograms of 
~- putrefaciens 
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Gentamicin 12 12/12 100 
Tobramycin NT NT NT 
Kanamycin 12 12/12 100 
Neomycin 12 12/12 100 
Streptomycin 12 12/12 100 
Polymixin B 12 12/12 100 
Carben i c i11 in NT NT NT 
Ampicil1 in 6 6/12 50 
Penicillin 0 0/12 0 
Chloramphenicol 12 12/12 100 
Tetracycline 10 10/12 83 
Cephalothin 3 3/12 25 
Lincomycin 0 0/12 0 
Erythromycin 10 10/12 83 
Gantrisin NT NT NT 
Nalidixic Acid 12 12/12 100 
Nitrofurantoin 12 12/12 100 
*=Numbers in each column indicate number of positive strains. 
NT signifies not tested. Susceptibilities are not intended 
as a therapeutic guide but are used as supplemental data for 
i dent ifi cation. 
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Table 29* 1 
Antibiogram Sumnary for the Pseudomonads 1 
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Gentamicin 92 69 64 100 57 31 89 86 100 100 
1 Tobramycin 94 100 100 100 NT NT NT NT NT NT 
Kanamycin 12 84 95 89 57 29 93 100 61 100 
1 Neomycin 11 48 55 90 NT 53 100 NT NT 100 
Streptomycin 13 48 57 88 14 33 33 29 65 100 
1 Polymyxin B 99 95 100 100 NT 96 NT NT NT 100 
Carbenicillin 81 1 0 98 14 19 100 100 100 NT 1 
Ampicillin 5 0 0 80 0 4 11 37 55 50 
1 Penicillin 0 0 0 0 NT NT NT NT NT 0 
Chloramphenicol 10 14 44 74 100 83 100 84 86 100 
1 Tetracycline 6 45 69 90 0 43 90 100 98 83 
Cephalothin 0 0 23 37 0 17 47 32 41 25 
1 Lincomycin 0 0 0 0 NT 0 0 NT NT 0 
Erythromycin 0 0 0 96 NT 74 92 100 96 83 
1 Gantrisin 4 0 0 0 NT NT NT NT NT NT 
Nalidixic Acid 4 0 28 85 100 94 5 89 84 100 1 
Nitrofurantoin 0 0 0 0 0 3 0 0 0 100 
1 
*=Numbers in each column indicate percent susceptible. NT signifies 
1 not tested. 
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Table 30* 1 
Scheme for the Identification of 
1 Clinically Isolated Pseudomonads 
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Anaerobic 
1 Dextrose 0 0 0 0 0 0 0 0 0 0 
Arginine 
1 Dihydrolase 99 99 98 12 0 0 0 24 44 0 
Nitrogen Gas 81 0 98 0 0 0 0 0 0 
. 1 Xylose 96 96 95 100 98 42 0 0 40 5 
Aerobic 
1 Dextrose 99 100 100 100 100 81 0 0 58 100 
Citrate 99 100 100 88 100 28 0 25 32 NT 
1 Oxidase 100 100 100 100 87 7 100 100 100 100 
Growth on ss 95 98 95 89 2 7 0 10 73 95 
1 Growth on 42C 100 0 0 99 68 78 100 86 95 100 
ONPG 1 1 2 0 93 83 0 0 0 0 
1 Gelatin 
Hydrolysis 89 0 99 0 67 100 79 7 0 100 
1 Gluconate 93 75 67 1 17 0 0 0 0 0 
Carbenicillin 81 1 0 98 18 19 100 100 100 NT 
1 Ampicillin 5 0 0 80 0 4 11 37 55 50 
Erythromycin 0 0 0 96 NT 74 92 100 96 83 1 
Nalidixic Acid 4 0 28 85 100 94 5 89 84 100 
1 QJ (IJ I I > > .- ~ QJ <lJ 
·~ ·~ 
"' Q > > ..., ..., X ·~ ·~ 
1 
·~ 
"' 
0 0 ..., ..., 
Remarks <II Ol .CI<lJ 
.Cl QJ 
"' 
·~ 
0 Q) l-> S..> 
"' 
<II QJ 
0... z ro·~ ro·~ QJ 0 > 
U+' U+' z 0. ·~ 
<lJ <lJ QJ·~ wro +' 
1 
Ill 
"' 
DVl Cl 0> Q) QJ ·~ 
0 0 0 <lJ Vl Vl 
"' c <: <lJO.. <lJZ 0 0 0 
·~ ·~ c s::: +' +' a. 
.0 .Cl ·~ QJ ·~ <lJ u u 
1 
"' "' 
V>Vl V!Vl ::> :::l til 
s.. l-
"'"' "'"' 
l- s.. 
"' .,; .,; -' -' u. u. ::c 
Table 30. (continued) 
*~Numbers in each column indicate percent positive for bio-
chemical tests and percent susceptible for antimicrobial 
agents. NT signifies not tested. 
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VIII. PROCEDURES 
Acetamide 
One tablet and one ml of distilled water are added 
to a 16 X 100 mm screw top test tube. The test tube is 
then boiled for ten minutes and allowed to cool. A heavy 
suspension of bacteria is used as the inoculum. Incubation 
is from four to six days with daily inspection. A positive 
test is seen as a color change from yellow (acidic) to pur-
ple (basic). 
Antimicrobial Susceptibility Testing 
The Mueller-Hinton plates, 150 mm in diameter, are 
stored in the refrigerator, in plastic bags until used or 
for a maximum of 14 days. The susceptibility testing pro-
cedure is as follows: The test organism is introduced into 
a nutrient broth tube and incubated until the density of 
the bacterial suspension, based on visual observation, is 
approximately equal to that of a 1% BaC1 2 in H2so4 standard 
(0.5 ml of a 1% BaC1 2 solution in 99.5 ml of 0.36 N H2so4 ). 
If the bacterial suspension is too turbid it is diluted 
with sterile nutrient broth. The suspension is streaked 
on a Mueller-Hinton plate with a sterile cotton swab after 
excess moisture is removed by pressing the swab to the 
inner wall of the test tube. The plates are evenly streaked 
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59 
using the "three plane" method to insure equal distribution 
of bacteria. The surface of each plate is allowed to dry 
for at least five minutes but not longer than 10 minutes. 
Antibiotic discs are then placed on the plates using a 
12 m::tgazine-150 mm dispenser (Difco). The plates are incu-
bated for 18 to 24 hours. The diameter of each zone of 
inhibition is measured twice and the average recorded. 
Carbohydrate Oxidation 
Each carbohydrate (lactose, fructose, maltose, mannitol, 
arabinose or rhamnose) is tested using the same procedure. 
One C.O.T. sugar tablet is placed in a 16 X 100 mm screw 
top test tube and one ml of sterile distilled water is added. 
The test tube is then boiled for ten minutes a~d alleged to 
cool. The tube is inoculated with a thick suspension of 
bacterial growth. Incubation is for one to four days with 
readings being made daily. Carbohydrate oxidation is re-
vealed as a color change from red to yellow. 
Gelatin Hydrolysis 
A single gelatin strip is placed in a 16 X 100 mm 
screw top test tube containing one ml of sterile distilled 
water. The test tube is then inoculated with a heavy sus-
pension of bacteria and incubated for 24-72 hours. Pro-
teolysis is indicated by the digestion of the gelatin layer 
and the exposure of the blue plastic supporting base. 
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Gluconate 
A gluconate substrate tablet is placed into a 16 X 
100 mm screw top test tube containing one ml of sterile 
distilled water. The tube is then heavily inoculated with 
bacteria. The test tube is then incubated for 18 to 24 
hours. After incubation a test for reducing sugars is 
carried out. A Clinitest Reagent Tablet (Ames Company, 
Elkhart, Indiana) is dropped into the test tube and allowed 
to react with the contents. During the reaction and for 
15 seconds thereafter the test tube should not be shaken. 
A positive test for reducing sugars is the appearance of a 
green, orange or brick-red color. Color changes developing 
after the 15 second waiting period should be disregarded. 
Growth at 42C 
Inoculate a 16 x 125 mm screw top test tube of a tryp-
tic soy agar slant with the bacteria to be tested.. Incu-
bate the slant in a 42C (~ 0.5C) water bath for 24 hours, 
and observe for growth. 
Growth on SS Agar 
Salmonella-Shigella Agar is prepared by suspending 
60 grams of dehydrated media in 1000 ml of distilled water. 
The solution is heated to boiling and without autoclaving 
poured into 15 X 100 mm petri plates. The plates are 
inoculated by streaking with a loop and incubated for 24 
hours. 
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Indole 
Five ml aliquot of 1.0% solution of tryptone broth in 
distilled water is dispensed into 16 X 125 mm screw top test 
tubes, autoclaved at 121C for 15 minutes, inoculated and 
incubated for 24 hours. A half ml of Kovacs' Reagent (para-
dimethylaminobenzaldehyde 5 g, plus 75 ml isoamyl alcohol, 
in 25 ml concentrated hydrochloric acid) is added and the 
tube is gently shaken. The appearance within one minute of 
a red color at the surface indicates a positive test for 
indole production. 
Oxi/Ferm Tube 
A single inoculating needle runs the length of the plas-
tic tube piercing through the center of each of the eight 
compartments which make up the OxijFerm tube. The compart-
ment labeled 'H2S/Indole' allows for the simultaneous testing 
of both of these characteristics. Indole production, however, 
was determined through separate testing as indicated above. 
The plastic cap covering the inoculating needle is unscrewed, 
the needle drawn out of the tube, and introduced into the 
stock culture slant to obtain a large (visible) inoculum and 
then, with a twisting motion, re-inserted through all eight 
compartments. The needle is then pulled back so that its 
tip is seen in the H2Sjindole compartment. The portion of the 
needle extending outside the tube is broken off and discarded 
into a disinfectant jar. The plastic cap is replaced and 
aerobic conditions created in the xylose, aerobic-dextrose, 
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urea, and citrate compartments by removing a strip of tape 
which covers air holes in these compartments. The OxifFerm 
tube is then incubated for 48 hours. 
After incubation results are determined for most tests 
by the observation of a color change or lack of a color change 
in the test compartments. Positive tests for the fermenta-
tion of anaerobic-dextrose, oxidative attack of xylose and 
aerobic-dextrose are seen as a color change in these compart-
ments from green to yellow, and for arginine dihydrolase as 
a change from green to purpole. Nitrogen gas production is 
seen as a separation of the wax overlay from the agar surface 
in the compartment labeled N2 gas. The H2S/Indole compart-
ment is observed for the formation of a black precipitate 
which indicates hydrogen sulfide production. Detection of 
urease is accomplished by the observation of a color change 
in the compartment labeled urea from yellow to red-purple. 
Organisms capable of utilizing sodium citrate as a sole source 
of carbon turn the green citrate compartment deep blue. 
The above tests along with the results of an oxidase 
test have been processed with a computer using binary code 
logic developed by Roche Diagnostics. This results in iden-
tification of a bacterial species according to a code number 
which is determined by the outcome of the various tests. 
The tests are grouped and within each group each test is 
given a different value. The value of the positive tests 
within each group are summed and a four-digit 'I.D. Value' 
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is obtained. The I.D. Value in the code booklet identifies 1 
the organism to the generic, specific or "group" level. 
1 
Oxidase 1 
To run the test, isolated bacteria from a plate or 1 
slant are picked up with a sterile loop and rubbed into the 
1 
test strip (Patho Tee). A positive test will turn the rubbed 
1 
area on the test strip blue within 30 seconds. The absence 
of a blue color is a negative test. 1 
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